Printed from https://fiscalreceipts.com/program/0604125D8Z/ — data as of August 12, 2026. Every figure is citation-backed; see the page online for per-number provenance.
Advanced Manufacturing Components and Prototypes
Budget Figures
FY2026 award data is a partial year — USASpending awards are reported on a rolling basis and the fiscal year does not close until September 30. why partial FY2026 data? →
| Fiscal year | Amount |
|---|---|
| FY24 | $0P-40 detail · PB2026 |
| FY25 | $21.8MR-1 TOA · PB2026 |
| FY26 | $45.5MR-1 TOA · PB2026 |
The vertical scale does not start at zero: the baseline sits just below this program’s smallest year, so a low point on this line is not a small amount. Read the shape for direction and the grid below for the figures.
● actuals (line) · ○ enacted · ◇ request — gaps are editions the program is absent from, never interpolated.
| Series | FY25 | FY26 |
|---|---|---|
| Enacted | $21.8M | |
| Request | $16.8M | $45.5M |
blank = series not published for this year; – = absent from that edition.
Program Lineage
No predecessor/successor lineage was recorded for this program element — no FY-to-FY transfer into or out of this line was stated in the ingested J-books, and none was inferred from the program structure.
Description
Mission — Advanced Manufacturing Components and Prototypes
The Advanced Manufacturing Components and Prototypes (AMCAP) program is established to validate the build and/or expansion of advanced manufacturing infrastructure and conduct research, develop, test, and evaluation (RDT&E) to facilitate development and transition of promising advanced manufacturing technologies to higher manufacturing readiness levels (MRL) via component and prototype development. Funding for this program is focused on requirements emerging from the Defense Biomanufacturing Strategy, which is guiding the execution of the Distributed Bioindustrial Manufacturing Program (DBIMP) – formerly known as the Manufacturing Enabled by Modular and Reusable (MEMBR) assets initiative investments to scale up domestic manufacturing of bioindustrial products. The project under this program will cover the full range of technologies critical to the Department of Defense (DoD) and manufacturing technologies with dual-use commercial applications to support the industrial base that will supply the DoD.
Mission — Advanced Manufacturing Components and Prototypes
This project will mature manufacturing processes to support the transition of advanced manufacturing components and prototypes to address warfighter needs. With initial emphasis in the bioindustrial manufacturing area, the project will advance the scale up production of molecules of interest. Through the biotechnology Distributed Bioindustrial Manufacturing Program (DBIMP) – formerly known as the Manufacturing Enabled by Modular Bioindustrial & Reusable (MEMBR) assets initiative - the project will establish a network of flexible manufacturing facilities to scale-up promising biotechnology capabilities for integration into DoD missions.
Justification
Accomplishments & Planned Programs (1)
Pilot-Scale Production of Bioindustrial Products
Bioindustrial projects to scale up promising molecules utilizing flexible bioindustrial manufacturing facilities. Biotechnology activities could include, but are not limited to, initial pilot or production scale batches, producing material needed for qualification to a military or commercial specification, test batches to facilitate the technology transfer from a pilot facility to an industrial scale facility, development of downstream processing techniques at scale, standard operating procedure (SOP) development, and test and evaluation. The biotechnology projects are to be performed in bioindustrial infrastructure funded by DoD.
Budget Line Items(workbook-cited)
P-1/R-1 workbook Total Obligation Authority basis (USD thousands) · PB2026.
Exhibit R-1
| Account | Org | Type | Amount |
|---|---|---|---|
| Research, Development, Test and Evaluation, Defense-Wide | OSD | FY25 Enacted | $21.8M |
| Research, Development, Test and Evaluation, Defense-Wide | OSD | FY25 Total | $21.8M |
| Research, Development, Test and Evaluation, Defense-Wide | OSD | FY26 Disc. Request | $45.5M |
| Research, Development, Test and Evaluation, Defense-Wide | OSD | FY26 Total | $45.5M |
Budget Details(R-2/P-40 facts)
J-book detail basis (R-2/P-40, USD millions) · PB2026 — a different accounting basis from the P-1/R-1 workbook TOA above; where the two disagree, the reconciliation strip under Budget Figures shows both.
Wider than this screen — swipe the table sideways for the remaining fiscal-year columns.
| Project | All Prior Years | FY24 Actuals | FY25 Total | FY26 Base | FY26 Request |
|---|---|---|---|---|---|
| Program Element | $0 | $0 | $21.8M | $45.5M | $45.5M |
| 232: Advanced Manufacturing Components and Prototypes | $0 | $0 | $21.8M | $45.5M | $45.5M |
No follow-the-dollar view — this program's awards haven't been crosswalked at high confidence (flows cover 17 of 1,741 programs). why coverage is partial? →
Awards
No awards are linked to this program element at high confidence — the budget→award crosswalk only asserts links it can defend, and this line has none yet.
Lobbying Mentions
No Senate LDA lobbying filing in the tracked data mentions this program element by code or alias.
Oversight
Department-level designation (not specific to this program)
GAO lists 5 high-risk areas for DOD as a whole. That designation covers the department, not Advanced Manufacturing Components and Prototypes — no program-specific GAO finding for this line is in the ingested data. See the DOD oversight record.
No research dossier for this program — dossiers cover 50 of 1,741 programs, the largest fully J-book-detailed lines by FY2026 requested dollars. why no dossier here? →